✦ LIBER ✦

Etanercept plus methotrexate slows the TEMPO of RA progression

✍ Scribed by Bankhead,, C

Book ID: 120858991
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2003
Weight: 181 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200314180-00033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Etanercept approved for use with methotr

Etanercept approved for use with methotrexate in active RA in the EU

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Disconnect between inflammation and join

Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: Results from the trial of etanercept and methotrexate with radiographic and patient outcomes

✍ Robert Landewé; Désirée van der Heijde; Lars Klareskog; Ronald van Vollenhoven; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

The effect of triple therapy versus etan

The effect of triple therapy versus etanercept plus methotrexate in rheumatoid arthritis: Comment on the article by Moreland et al

✍ Graudal, Niels; Jürgens, Gesche 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 33 KB

A randomized comparative effectiveness s

A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trial

✍ Larry W. Moreland; James R. O'Dell; Harold E. Paulus; Jeffrey R. Curtis; Joan M. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB

Comparison of etanercept and methotrexat

Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: Two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial

✍ Désirée van der Heijde; Lars Klareskog; Vicente Rodriguez-Valverde; Catalin Codr 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB 👁 3 views

P31 Abatacept increases the proportion o

P31 Abatacept increases the proportion of patients who remain free from structural damage progression through 5 years in methotrexate inadequate responders with RA

✍ Gregory Macaraeg; K Genant; C Peterfy; R Westhovens; JC Becker; G Vratsanos; X Z 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 64 KB